Company Analysis

Stevanato Group S.p.A. (STVN)

NYSE: STVN · Surgical & Medical Instruments & Apparatus · filing with the SEC since 2021
Grade5.5
◀ Past 7.5● Present 5.6▶ Future 3.3
1 est.

Who owns Stevanato Group S.p.A.

As filed with the SEC
Holders of 5% or more
6
Conestoga Capital Advisors holds 16.7% of Common Stock, as its SCHEDULE 13G/A filed Jan 9, 2026 says.
Directors and officers
13
report now, of 13 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 6 named at left.
Holders of 5% or moreshare of the class, as filed
Conestoga Capital Advisors
SCHEDULE 13G/A · filed Jan 9, 2026 · Common Stock · 17.4% in Jan 10, 2025
16.7%
Neuberger Berman Group LLC
10%
Van Berkom & Associates Inc.
6%
Thrivent Financial For Lutherans
5.6%
Artisan Partners Asset Management Inc.
SCHEDULE 13G · filed Aug 13, 2026 · Ordinary Shares · 4.7% in Feb 3, 2026
5.2%
Baron Capital Group, Inc.
SCHEDULE 13G · filed May 15, 2026 · Ordinary shares without par value
5.03%
Lazard Asset Management LLC
SCHEDULE 13G · filed Nov 14, 2024 · Common Stock · reported falling below 5%
under 5%
Wellington Management Group LLP
SCHEDULE 13G/A · filed Feb 10, 2025 · Common Stock · reported falling below 5%
under 5%
T. Rowe Price Investment Management, Inc.
SCHEDULE 13G/A · filed Aug 14, 2026 · COMMON STOCK · reported falling below 5%, from 6.5% in May 15, 2026
under 5%
What STVN reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Medical Glass A S
An entity · subsidiary · owns, named in the 20-F filed Mar 4, 2026

15 subsidiaries in 11 countries, from the list filed with the 20-F filed Mar 4, 2026.

Insider tradesForm 4
8sales
2purchases
0sales on a scheduled plan
8people selling
$600,000sold, in dollars
$600,000bought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
26
2026 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window8 of 13 on the roster
PersonRole as filedSalesSoldOn a planBuysBought
Stocchi MauroChief Business Strategy Officer1$300,00000$0
Dal Lago MarcoChief Financial Officer1$100,00000$0
Federici William Jdirector1$001$300,000
Morel Donald E Jrdirector1$001$300,000
Magistretti Elisabettadirector1$000$0
Santel Lucianodirector1$000$0
Balachandran Madhavandirector1$000$0
Flynn Karendirector1$000$0
SI Assistanton STVN · research, not advice